The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Ivory Coast launches first vaccination drive with COVAX shots

Mon, 01st Mar 2021 12:07

* Ivory Coast vaccination to focus on Abidjan first

* Targets 3% of population in first phase

* Ghana's president takes first jab ahead of Tuesday launch

* COVAX scheme to deliver 11 mln doses in the next week

*
(Adds WHO quote, details about new deliveries)

By Loucoumane Coulibaly

ABIDJAN, March 1 (Reuters) - Ivory Coast launched the
world's first COVID-19 inoculation drive on Monday with doses
imported from the COVAX sharing facility, a milestone in the
race to extend vaccine access to poorer countries.

Patrick Achi, the secretary-general at the presidency, was
the first to be vaccinated at a sports complex in the commercial
capital Abidjan. Onlookers cheered as a health worker in a white
coat and pink scrubs delivered the injection.

Medical personnel, teachers and security forces members were
also being vaccinated in the first phase of the campaign
targeting 3% of the population.

"The vaccines offer us the hope of returning to normal in
the coming months," Achi said.

Ivory Coast has recorded 36,109 infections and 192
coronavirus-related deaths.

COVAX, which is led by the GAVI vaccines alliance along with
the World Health Organization (WHO) and other partners, aims to
deliver over 1.3 billion doses to 92 low- and middle-income
countries, covering up to 20% of their populations.

The initiative hopes to level a playing field that has seen
wealthier nations vaccinate millions while comparatively few
have received shots in poorer parts of the world. Only a handful
of African countries have begun inoculating their citizens with
vaccines purchased bilaterally or received as donations.

"This is a day many of us have been dreaming of and working
for more than 12 months," said WHO Director-General Tedros
Adhanom Ghebreyesus.

In the next week, COVAX expects to deliver 11 million doses
of the AstraZeneca/Oxford and Pfizer/BioNTech
vaccines, it said in a statement.

The allocation of the AstraZeneca/Oxford vaccine to be
delivered to participating countries between now and the end of
May is expected on Tuesday, it added.

'WHY BE SCARED?'

Even with free doses from COVAX, many poorer countries will
struggle to reach herd immunity any time soon and must find
financing for distribution and community outreach.

Ivory Coast received 504,000 doses of the AstraZeneca/Oxford
vaccine from COVAX on Friday. After the first phase, it plans to
expand access to people over 50, those with chronic diseases and
travellers.

Over a hundred people lined up early on Monday outside the
complex in Abidjan's Treichville neighbourhood to receive their
first shot.

"Why be scared?" asked David Elloh, a teacher, after being
vaccinated. "It's a vaccine like any other. I am relieved."

Africa has reported relatively few COVID-19 deaths compared
to other continents, but the death toll has been rising fast as
a second wave of infections overwhelms hospitals.

Ivory Coast's neighbour Ghana, which last week became the
first country to receive a delivery of vaccines from COVAX,
plans to officially begin its vaccination campaign on Tuesday.

On Monday, Ghanaian President Nana Akufo-Addo and his wife
received the vaccine at a military hospital in an effort to
boost public confidence ahead of the campaign.

"It is important that I set the example that this vaccine is
safe by being the first to have it," Akufo-Addo said.
(Reporting by Loucoumane Coulibaly and Ange Aboa in Abidjan
Additional reporting by Christian Akorlie in Accra and Stephanie
Nebehay in Geneva
Writing by Aaron Ross
Editing by Bate Felix, Bernadette Baum and Giles Elgood)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.